FR2364928A1 - Procede de preparation de steroides halogenes en position 9,11, et les composes obtenus par le procede - Google Patents
Procede de preparation de steroides halogenes en position 9,11, et les composes obtenus par le procedeInfo
- Publication number
- FR2364928A1 FR2364928A1 FR7727739A FR7727739A FR2364928A1 FR 2364928 A1 FR2364928 A1 FR 2364928A1 FR 7727739 A FR7727739 A FR 7727739A FR 7727739 A FR7727739 A FR 7727739A FR 2364928 A1 FR2364928 A1 FR 2364928A1
- Authority
- FR
- France
- Prior art keywords
- preparation
- compounds obtained
- halogen steroids
- steroids
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU75809A LU75809A1 (de) | 1976-09-16 | 1976-09-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2364928A1 true FR2364928A1 (fr) | 1978-04-14 |
FR2364928B1 FR2364928B1 (de) | 1981-03-06 |
Family
ID=19728351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7727739A Granted FR2364928A1 (fr) | 1976-09-16 | 1977-09-14 | Procede de preparation de steroides halogenes en position 9,11, et les composes obtenus par le procede |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS5337652A (de) |
AT (1) | AT356303B (de) |
AU (1) | AU514425B2 (de) |
BE (1) | BE858709A (de) |
CA (1) | CA1105003A (de) |
DE (1) | DE2741067A1 (de) |
DK (1) | DK410077A (de) |
FR (1) | FR2364928A1 (de) |
GB (1) | GB1584826A (de) |
LU (1) | LU75809A1 (de) |
NL (1) | NL7710086A (de) |
SE (1) | SE7710337L (de) |
ZA (1) | ZA775537B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0029151A2 (de) * | 1979-11-16 | 1981-05-27 | STEROSYNT Ltd. | 6-Alpha-fluor-9-alpha-chlor-prednisolon-17,21-Diester, pharmazeutische Zusammensetzungen, die sie enthalten, und Zwischenprodukte |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1209140B (it) * | 1979-11-16 | 1989-07-10 | Prochem Ets | 6 alfa-fluoro-prednisolone 17,21-diesteri. |
-
1976
- 1976-09-16 LU LU75809A patent/LU75809A1/xx unknown
-
1977
- 1977-09-13 DE DE19772741067 patent/DE2741067A1/de not_active Withdrawn
- 1977-09-14 CA CA286,727A patent/CA1105003A/en not_active Expired
- 1977-09-14 FR FR7727739A patent/FR2364928A1/fr active Granted
- 1977-09-14 GB GB38343/77A patent/GB1584826A/en not_active Expired
- 1977-09-14 NL NL7710086A patent/NL7710086A/xx not_active Application Discontinuation
- 1977-09-15 ZA ZA00775537A patent/ZA775537B/xx unknown
- 1977-09-15 BE BE180914A patent/BE858709A/xx unknown
- 1977-09-15 SE SE7710337A patent/SE7710337L/ not_active Application Discontinuation
- 1977-09-15 AU AU28848/77A patent/AU514425B2/en not_active Expired
- 1977-09-15 DK DK410077A patent/DK410077A/da unknown
- 1977-09-15 AT AT663077A patent/AT356303B/de not_active IP Right Cessation
- 1977-09-16 JP JP11060977A patent/JPS5337652A/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0029151A2 (de) * | 1979-11-16 | 1981-05-27 | STEROSYNT Ltd. | 6-Alpha-fluor-9-alpha-chlor-prednisolon-17,21-Diester, pharmazeutische Zusammensetzungen, die sie enthalten, und Zwischenprodukte |
EP0029151A3 (en) * | 1979-11-16 | 1981-08-26 | Sterosynt Ltd. | 6-alpha-fluoro-9-alpha-chloro-prednisolone-17,21 diesters, pharmaceutical compositions containing them and intermediates |
Also Published As
Publication number | Publication date |
---|---|
CA1105003A (en) | 1981-07-14 |
ZA775537B (en) | 1978-07-26 |
DK410077A (da) | 1978-03-17 |
ATA663077A (de) | 1979-09-15 |
GB1584826A (en) | 1981-02-18 |
LU75809A1 (de) | 1978-05-12 |
AT356303B (de) | 1980-04-25 |
FR2364928B1 (de) | 1981-03-06 |
JPS5337652A (en) | 1978-04-06 |
DE2741067A1 (de) | 1978-03-23 |
BE858709A (fr) | 1978-03-15 |
AU514425B2 (en) | 1981-02-12 |
NL7710086A (nl) | 1978-03-20 |
SE7710337L (sv) | 1978-03-17 |
AU2884877A (en) | 1979-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8104993A1 (es) | Un procedimiento para preparar compuestos aromaticos susti- tuidos | |
FR2442227A1 (fr) | Procede de production d'acides threo-3-amino-2-hydroxybutanoylaminoacetiques | |
FR2432007A1 (fr) | Procede de preparation de methacroleine | |
FR2400021A1 (fr) | Preparation d'acide (1r,cis);caronaldehydique | |
FR2382440A1 (fr) | Procede d'obtention de phenates metalliques, notamment de phenates de calcium | |
FR2383907A1 (fr) | Procede de preparation de derives de l'acide acetique et derives obtenus par ce procede | |
FR2387219A1 (de) | ||
FR2364928A1 (fr) | Procede de preparation de steroides halogenes en position 9,11, et les composes obtenus par le procede | |
FR2433538A1 (fr) | Procede de synthese de 16-pregnanes a partir de 17(20)-steroides | |
FR2445322A1 (fr) | Preparation de la cimetidine | |
FR2379587A1 (fr) | Procede de preparation de liants a base d'urethanne deposables a la cathode | |
FR2418220A1 (fr) | Composes d'ammonium quaternaires utilises pour l'assouplissement des etoffes | |
FR2355819A1 (fr) | Procede pour la preparation de composes oxo cycliques | |
FR2433541A1 (fr) | Nouveau procede de preparation de certains steroides | |
FR2376104A1 (fr) | Procede pour la chloration dirigee d'alcoylbenzenes | |
BE905409A (fr) | Procede de preparation de n-sulfamyl-3-(2-guanidino-thiazol-4-yl-methylthio)-propionamidine. | |
BE904662A (fr) | Derive antipsychotique du benzisothiazole s-oxyde. | |
FR2388826A1 (fr) | Preparation de 1-n-(o)amino-a-hydroxyalkanoy) kanamycines | |
FR2375252A1 (fr) | Nouveaux glucosides antitumoraux | |
FR2387996A1 (fr) | Procede de preparation de l'auranofine | |
FR2397417A1 (fr) | Procede de preparation de derives de la thienopyridine | |
FR2453162A1 (fr) | Procede pour la preparation de derives de 4-acetoxy-azetidine-2-one par condensation avec un b-thiocetoester et composes obtenus | |
FR2361372A1 (fr) | Procede de preparation de la 2,4-diamino-5-(3', 4', 5'-trimethoxybenzyl)-pyrimidine | |
FR2357527A1 (fr) | Nouveau procede de synthese du chlorhydrate de derives particuliers de catecholamine | |
JPS57179197A (en) | 17 alpha-alkyne-17 beta-hydroxy-1 alpha- methyl-4-androstene-3-one, manufacture and medicine having anti-androgenic activity and fat production inhibiting activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |